ARTSCAN III: a randomized phase III study comparing chemoradiotherapy with cisplatin versus cetuximab in patients with locoregionally advanced head and neck …
M Gebre-Medhin, E Brun, P Engström… - Journal of Clinical …, 2021 - ascopubs.org
PURPOSE We performed an open-label randomized controlled phase III study comparing
treatment outcome and toxicity between radiotherapy (RT) with concomitant cisplatin versus …
treatment outcome and toxicity between radiotherapy (RT) with concomitant cisplatin versus …
Salivary gland transfer to prevent radiation-induced xerostomia: a systematic review and meta-analysis
AJ Sood, NF Fox, BP O'Connell, TL Lovelace… - Oral oncology, 2014 - Elsevier
Salivary gland transfer (SGT) has the potential to prevent radiation-induced xerostomia. We
attempt to analyze the efficacy of SGT in prevention of xerostomia and maintenance of …
attempt to analyze the efficacy of SGT in prevention of xerostomia and maintenance of …
The role of tumor volume in radiotherapy of patients with head and neck cancer
T Rutkowski - Radiation Oncology, 2014 - Springer
The assumption that the larger tumor contains a higher number of clonogenic cells what may
deteriorate prognosis of patients treated with RT has been confirmed in many clinical …
deteriorate prognosis of patients treated with RT has been confirmed in many clinical …
Improved survival using intensity‐modulated radiation therapy in head and neck cancers: a SEER‐Medicare analysis
BACKGROUND Intensity‐modulated radiation therapy (IMRT) is a technologically
advanced, and more expensive, method of delivering radiation therapy with a goal of …
advanced, and more expensive, method of delivering radiation therapy with a goal of …
FDG PET/CT imaging of oropharyngeal squamous cell carcinoma: characteristics of human papillomavirus–positive and–negative tumors
AK Tahari, KC Alluri, H Quon, W Koch… - Clinical nuclear …, 2014 - journals.lww.com
Objective The objective of this study was to assess differences in morphological and
glycolytic characteristics of primary tumors and locoregional nodal disease between human …
glycolytic characteristics of primary tumors and locoregional nodal disease between human …
Primary tumor volume and prognosis for patients with p16-positive and p16-negative oropharyngeal squamous cell carcinoma treated with radiation therapy
G Adrian, H Carlsson, E Kjellén, J Sjövall… - Radiation …, 2022 - Springer
Background The prescribed radiation dose to patients with oropharyngeal squamous cell
carcinoma (OPSCC) is standardized, even if the prognosis for individual patients may differ …
carcinoma (OPSCC) is standardized, even if the prognosis for individual patients may differ …
Local recurrences after curative IMRT for HNSCC: Effect of different GTV to high-dose CTV margins
Introduction The aim was to analyze position of CT-verified local recurrences (LR) and local
control (LC) among three centers that used different GTV to CTV1 margins. Materials and …
control (LC) among three centers that used different GTV to CTV1 margins. Materials and …
Superior prognostic utility of gross and metabolic tumor volume compared to standardized uptake value using PET/CT in head and neck squamous cell carcinoma …
PB Romesser, MM Qureshi, BA Shah… - Annals of nuclear …, 2012 - Springer
Objective To compare the prognostic utility of the 2-[18 F] fluoro-2-deoxy-d-glucose (FDG)
maximum standardized uptake value (SUV max), primary gross tumor volume (GTV), and …
maximum standardized uptake value (SUV max), primary gross tumor volume (GTV), and …
Refining risk stratification for locoregional failure after chemoradiotherapy in human papillomavirus-associated oropharyngeal cancer
JM Vainshtein, ME Spector, JB McHugh, KK Wong… - Oral oncology, 2014 - Elsevier
Background To determine whether the addition of molecular and imaging biomarkers to
established clinical risk factors could help predict locoregional failure (LRF) after …
established clinical risk factors could help predict locoregional failure (LRF) after …
Quantitative diffusion-weighted imaging analyses to predict response to neoadjuvant immunotherapy in patients with locally advanced head and neck carcinoma
HJ van der Hulst, JL Vos, R Tissier, LA Smit… - Cancers, 2022 - mdpi.com
Simple Summary Immunotherapy may induce early treatment response in head and neck
squamous cell carcinoma (HNSCC) for some patients. Routine imaging parameters fail to …
squamous cell carcinoma (HNSCC) for some patients. Routine imaging parameters fail to …